75 related articles for article (PubMed ID: 37245784)
1. Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
Dickinson JE; Doherty DA
Contraception; 2023 Sep; 125():110080. PubMed ID: 37245784
[TBL] [Abstract][Full Text] [Related]
2. Medical abortion in the second trimester - an update.
Kopp Kallner H
Curr Opin Obstet Gynecol; 2023 Dec; 35(6):490-495. PubMed ID: 37873766
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant misoprostol or mifepristone for cervical preparation with osmotic dilators before dilation and evacuation.
Lambert SJ; Lunde B; Porsch L; Stoffels G; MacIsaac L; Dayananda I; Dragoman MV
Contraception; 2024 Apr; 132():110364. PubMed ID: 38218312
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rates of adverse events in adolescent and adult women undergoing medical abortion: population register based study.
Niinimäki M; Suhonen S; Mentula M; Hemminki E; Heikinheimo O; Gissler M
BMJ; 2011 Apr; 342():d2111. PubMed ID: 21508042
[TBL] [Abstract][Full Text] [Related]
5. One-day versus two-day mifepristone-misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study.
Sium AF; Teklu H; Reeves M; Tolu LB; Prager S
Contraception; 2024 Apr; 132():110356. PubMed ID: 38151223
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of combination RU 486-laminaria tents-misoprostol-peridural anesthesia in second and third trimester induced abortions].
Hoffer MC; Charlier C; Giacalone PL; Zimbris L; Astruc M; Boulot P
J Gynecol Obstet Biol Reprod (Paris); 1998 Jan; 27(1):83-6. PubMed ID: 9583050
[TBL] [Abstract][Full Text] [Related]
7. Cervical preparation for second-trimester procedural abortion.
Fraz F; Liu SM; Shaw KA
Curr Opin Obstet Gynecol; 2023 Dec; 35(6):470-475. PubMed ID: 37678155
[TBL] [Abstract][Full Text] [Related]
8. [Medical strategy for abortions between 14 and 16 weeks of gestation].
Bettahar K; Koch A; Deruelle P
Gynecol Obstet Fertil Senol; 2022 Nov; 50(11):735-740. PubMed ID: 36183986
[TBL] [Abstract][Full Text] [Related]
9. Significant adverse events and outcomes after medical abortion.
Cleland K; Creinin MD; Nucatola D; Nshom M; Trussell J
Obstet Gynecol; 2013 Jan; 121(1):166-71. PubMed ID: 23262942
[TBL] [Abstract][Full Text] [Related]
10. Laminaria, induced fetal demise and misoprostol in late abortion.
Hern WM
Int J Gynaecol Obstet; 2001 Dec; 75(3):279-86. PubMed ID: 11728490
[TBL] [Abstract][Full Text] [Related]
11. When Do Women with Second Trimester Pregnancy Loss Need Repeated Doses of Misoprostol? Insights from a Teaching Hospital.
Cohen N; Cohen B; Karmakar D; Lavie O; Zilberlicht A
Isr Med Assoc J; 2023 Dec; 25(12):799-803. PubMed ID: 38142318
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist provision of medication abortion: A pilot study.
Sandoval S; Rafie S; Kully G; Mody S; Averbach S
Contraception; 2024 Mar; 131():110346. PubMed ID: 38065286
[TBL] [Abstract][Full Text] [Related]
13. Prior Cesarean Birth and Risk of Uterine Rupture in Second-Trimester Medication Abortions Using Mifepristone and Misoprostol: A Systematic Review and Meta-analysis.
Henkel A; Miller HE; Zhang J; Lyell DJ; Shaw KA
Obstet Gynecol; 2023 Dec; 142(6):1357-1364. PubMed ID: 37884011
[TBL] [Abstract][Full Text] [Related]
14. Impact of approval of home use of misoprostol in England on access to medical abortion: An interrupted time series analysis.
Lewandowska M; Carter DJ; Gasparrini A; Lohr PA; Wellings K
Int J Gynaecol Obstet; 2024 Jan; 164(1):286-297. PubMed ID: 37621171
[TBL] [Abstract][Full Text] [Related]
15. Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation: Jointly developed with the Society for Maternal-Fetal Medicine.
Zwerling B; Edelman A; Jackson A; Burke A; Prabhu M
Am J Obstet Gynecol; 2023 Oct; ():. PubMed ID: 37821258
[TBL] [Abstract][Full Text] [Related]
16. Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation: Jointly developed with the Society for Maternal-Fetal Medicine.
Zwerling B; Edelman A; Jackson A; Burke A; Prabhu WTAOM
Contraception; 2023 Sep; ():110143. PubMed ID: 37821241
[TBL] [Abstract][Full Text] [Related]
17. Outpatient medical management of later second trimester abortion (18-23.6 weeks) with procedural evacuation backup: A large case series.
Chandrasekaran S; Ruggiero S; Goodrick G
Contracept X; 2024; 6():100104. PubMed ID: 38515629
[TBL] [Abstract][Full Text] [Related]
18. Changes in the numbers of hospital-based abortions and outpatient early medical abortions in Victoria, 2012-22: a retrospective cohort study.
Marzan MB; Johnson E; Moore P; Jiang H; Hui L
Med J Aust; 2024 Feb; 220(3):145-153. PubMed ID: 38305486
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of telehealth medication abortion in the USA.
Upadhyay UD; Koenig LR; Meckstroth K; Ko J; Valladares ES; Biggs MA
Nat Med; 2024 Apr; 30(4):1191-1198. PubMed ID: 38361123
[TBL] [Abstract][Full Text] [Related]
20. Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation.
Zwerling B; Edelman A; Jackson A; Burke A; Prabhu M
Contraception; 2023 Sep; ():110143. PubMed ID: 37820999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
